DrugPatentWatch Database Preview
Investigational Drug Information for OTO-104
Email this page to a colleague
What is the development status for investigational drug OTO-104?
OTO-104 is an investigational drug.
There have been 25 clinical trials for OTO-104.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 13th 2021.
The most common disease conditions in clinical trials are Meniere Disease, Otitis, and Otitis Media. The leading clinical trial sponsors are Otonomy, Inc., Sorlandet Hospital HF, and OHSU Knight Cancer Institute.
There is one US patent protecting this investigational drug and thirty-seven international patents.
Summary for OTO-104
| US Patents | 1,643 |
| International Patents | 37,160 |
| US Patent Applications | 5,273 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 155 |
| Clinical Trial Progress | Phase 3 (2021-01-13) |
| Vendors | 77 |
Recent Clinical Trials for OTO-104
| Title | Sponsor | Phase |
|---|---|---|
| OTO-313 in Subjects With Unilateral Subjective Tinnitus | Otonomy, Inc. | Phase 2 |
| Nasal Breathing and Physical Capacity | Sorlandet Hospital HF | Phase 4 |
| Tranexamic Acid Versus Epinephrine During Exploratory Tympanotomy | Assiut University | N/A |
Clinical Trial Summary for OTO-104
Top disease conditions for OTO-104
Top clinical trial sponsors for OTO-104
US Patents for OTO-104
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| OTO-104 | ⤷ Try it Free | Heterocyclic compounds useful in the treatment of disease | Epigen Biosciences, Inc. (San Diego, CA) | ⤷ Try it Free |
| OTO-104 | ⤷ Try it Free | Pyrazol-3-ones that activate pro-apoptotic BAX | Dana-Farber Cancer Institute, Inc. (Boston, MA) | ⤷ Try it Free |
| OTO-104 | ⤷ Try it Free | Heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | ⤷ Try it Free |
| OTO-104 | ⤷ Try it Free | Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders | Dana-Farber Cancer Institute, Inc. (Boston, MA) | ⤷ Try it Free |
| OTO-104 | ⤷ Try it Free | Phosphonate compounds for treatment of medical disorders | Achillion Pharmaceuticals, Inc. (New Haven, CT) | ⤷ Try it Free |
| OTO-104 | ⤷ Try it Free | IBAT inhibitors for the treatment of liver diseases | Albireo AB (Gothenburg, SE) | ⤷ Try it Free |
| OTO-104 | ⤷ Try it Free | Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus | Seattle Genetics, Inc. (Bothell, WA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for OTO-104
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| OTO-104 | Australia | AU2014232383 | 2033-03-15 | ⤷ Try it Free |
| OTO-104 | Australia | AU2019202731 | 2033-03-15 | ⤷ Try it Free |
| OTO-104 | Australia | AU2019288275 | 2033-03-15 | ⤷ Try it Free |
| OTO-104 | Brazil | BR112015023267 | 2033-03-15 | ⤷ Try it Free |
| OTO-104 | Brazil | BR112020025927 | 2033-03-15 | ⤷ Try it Free |
| OTO-104 | Canada | CA2906931 | 2033-03-15 | ⤷ Try it Free |
| OTO-104 | Canada | CA3046894 | 2033-03-15 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
